Ticker Details
Royalty Pharma plc
IPO Date:	June 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$27.3B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.55 | 1.42%
Avg Daily Range (30 D):	$0.83 | 1.43%
Avg Daily Range (90 D):	$0.83 | 1.50%

Institutional Daily Volume
Avg Daily Volume:	2.15M
Avg Daily Volume (30 D):	2.21M
Avg Daily Volume (90 D):	2.52M

Trade Size
Avg Trade Size (Sh.):	88
Avg Trade Size (Sh.) (30 D):	62
Avg Trade Size (Sh.) (90 D):	66

Institutional Trades
Total Institutional Trades:	10,533
Avg Institutional Trade:	$4.9M
Avg Institutional Trade (30 D):	$5.07M
Avg Institutional Trade (90 D):	$6.17M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	6

Market Closing Trades
Avg Closing Trade:	$15.79M
Avg Closing Trade (30 D):	$29.03M
Avg Closing Trade (90 D):	$35.98M
Avg Closing Volume:	416.55K

News

Apr 21, 2026 @ 5:00 PM Royalty Pharma Launches Global Translational Prize... Source: Na

Apr 17, 2026 @ 12:30 PM Royalty Pharma Declares Second Quarter 2026 Divide... Source: Na

Apr 1, 2026 @ 10:00 AM Zymeworks Appoints Kristin Stafford as Chief Finan... Source: Na

Mar 5, 2026 @ 2:00 PM Vera Therapeutics Appoints Christopher Hite to Boa... Source: Not Specified

Mar 2, 2026 @ 12:00 PM Royalty Pharma Appoints Kenneth Sun as Senior Vice... Source: Na

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$1.88	$.04	$.67
Diluted EPS	$1.88	$.04	$.67
Revenue	$2.54B	$674.14M	$630.58M
Gross Profit
Net Income / Loss	$1.35B	$81.49M	$468.26M
Operating Income / Loss	$1.51B	$133.12M	$563.04M
Cost of Revenue
Net Cash Flow	$180.08M	$225.59M	$-32.3M
PE Ratio

Splits
Oct 15, 2010	1:4